← Back to Search

Adductor Canal Block for Pain

Phase < 1
Waitlist Available
Research Sponsored by Henry Ford Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients over the age of 18 scheduled for primary total knee arthroplasty by four fellowship trained surgeons will be eligible for inclusion.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 3 days
Awards & highlights

Study Summary

This is a randomized, double blinded, standard of care controlled clinical trial. All adult patients over eighteen desiring total knee arthroplasty will be eligible. The study compares pain control, opioid consumption, and physical exam findings in patients undergoing total knee arthroplasty between patients receiving adductor canal block and those who receiving periarticular injection alone.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 3 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 3 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Distance Walked (meters)
Knee flexion and extension Range of Motion (ROM)
Pain with Ambulation (VAS)
+1 more
Secondary outcome measures
Pain Medication Intake
Time to discharge readiness

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Adductor Canal BlockExperimental Treatment4 Interventions
Patients in this group received local infiltration of bupivacaine in the adductor canal after surgery, in addition to the periarticular injection intra-op.
Group II: Periarticular InjectionPlacebo Group2 Interventions
Patients in this group received a bandaid at the presumed adductor canal injection site, in addition to the periarticular injection intra-op.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Adductor Canal Block
2016
Completed Phase 4
~870
Ropivacaine
FDA approved
Bupivacaine
FDA approved
Periarticular Injection
2016
Completed Phase 4
~400

Find a Location

Who is running the clinical trial?

Henry Ford Health SystemLead Sponsor
300 Previous Clinical Trials
2,099,871 Total Patients Enrolled
6 Trials studying Pain
312 Patients Enrolled for Pain

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Pain Control After Total Knee Arthroplasty: Benefit In Adding Single Shot Adductor Canal Block to Existing Pain Regimen Protocol?
Michael Charters, MD 2016. "Pain Control After Total Knee Arthroplasty: Benefit In Adding Single Shot Adductor Canal Block to Existing Pain Regimen Protocol?". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02740192.
~14 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top